Personalizing the Care of Patients With Atopic Dermatitis and Head and Neck Involvement

EBAC

Paris Expo Porte de Versailles / Pavillon 7 - Paris Convention Centre
Thursday, 18 September 2025 | 15:15 - 16:00 TZ
event presence logo
Supported by an independent educational grant from LEO Pharma A/S.

overview

Do you know how to effectively manage patients with moderate to severe atopic dermatitis (AD) involving the head and neck? Join our dynamic symposium where leading experts will cover the unique challenges and unmet needs of treating AD in these sensitive areas. During this engaging session, with a focus on enhancing patients' quality of life, discover personalized strategies for long-term disease control of AD with head and neck involvement. Elevate your practice and improve care for your AD patients.

IMPORTANT NOTICE

Registering through this page does not grant access to the EADV CONGRESS 2025 or to this symposium.

To attend this symposium, whether in person or virtually, you must first register directly with the EADV CONGRESS 2025.

Please visit the official congress website for full registration details and requirements.

HELD AT EADV CONGRESS 2025

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

MODERATOR / COURSE DIRECTOR

​​Raj Chovatiya, MD, PhD, MSCI

​Clinical Associate Professor of Medicine

​Rosalind Franklin University of Medicine and

Science Chicago Medical School

North Chicago, Illinois, United States ​

PANELIST

Chih-ho Hong, MD

​Clinical Professor 

​Department of Dermatology and Skin Science

​University of British Columbia

​Vancouver, British Columbia, Canada​

PANELIST

Stephan Weidinger, MD, PhD

​Chair and Director

​Department of Dermatology and Allergy

​University Medical Center Schleswig-Holstein

​Kiel, Germany​

AGENDA

15:15 TZ

Introduction and Welcome

Raj Chovatiya, MD, PhD, MSCI

15:18 TZ

Unmet Needs for Patients With Moderate to Severe Atopic Dermatitis (AD) With Head and Neck (H&N) Involvement

Stephan Weidinger, MD, PhD; Patient

15:25 TZ

The Current Treatment Landscape for Moderate to Severe AD

Raj Chovatiya, MD, PhD, MSCI; Chih-ho Hong, MD

15:35 TZ

How Would You Manage These Patients With Moderate to Severe AD and H&N Involvement?

Chih-ho Hong, MD; Stephan Weidinger, MD, PhD

15:50 TZ

Audience Q&A

Raj Chovatiya, MD, PhD, MSCI

15:58 TZ

Concluding Remarks / Followed by EBAC Evaluation

Raj Chovatiya, MD, PhD, MSCI
backstage pass
Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video encouraged*

LOCATION

Paris Expo Porte de Versailles / Pavillon 7 - Paris Convention Centre

1 Place de la Porte de Versailles

75015 Paris, France

ROOM: Hub 2 / LEVEL 7.2.1

TARGET AUDIENCE

This educational activity is intended for an audience of dermatologists and primary care.

GOAL STATEMENT

The goal of this activity is for learners to be better able to improve long-term outcomes for patients with moderate to severe atopic dermatitis (AD) and head and neck involvement by confidently applying a holistic patient-centric approach and selecting an appropriate targeted systemic therapy to achieve effective long-term disease control.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have increased knowledge regarding the[/para] [list][item]Key clinical data for biologic therapies to treat moderate to severe AD in specific body areas [item]Key considerations for treatment selection for a patient affected by moderate to severe AD with head and neck involvement [/list] [para]Have greater competence related to[/para] [list][item]Selecting a biologic therapy for a patient affected by moderate to severe AD with head and neck involvement [/list] [para]Demonstrate greater confidence in their ability to[/para] [list][item]Selecting an appropriate biologic therapy for a patient affected by moderate to severe AD with head and neck involvement [/list]

ACCREDITATION STATEMENT

WebMD Global LLC is an EBAC® accredited provider since 2024.
accreditation logo
webmd logo
[title]For Physicians[/title] [text]Total effective education time: 45 minutes. EBAC Activity ID #: 2025-EPN-9932000-000. [break] [break] Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC® CE credits/points to [italic]AMA PRA Category 1 Credits[/italic][super]TM[/super]. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to [italic]AMA PRA Category 1 Credit[/italic][super]TM[/super].  [/text]
© 2025 MedscapeLIVE! All Rights Reserved | Medscape Education Terms of Service | Privacy Policy